Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Outset Medical
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has end stage renal disease (ESRD) adequately treated by maintenance dialysis achieving a Kt/V ≥ 1.2 and has been deemed stable for at least three months by his/her treating nephrologist.
Subject has a well-functioning and stable vascular access that allows a blood flow of at least 300 ml/min.
You may not be if
Life expectancy less than 12 months from first study procedure.
Subject has had a recent major cardiovascular adverse event within the last 3 months.
Subject has New York Class III or IV Congestive Heart Failure, or ejection fraction less than 30%.
Subject with fluid overload due to intractable ascites secondary to liver cirrhosis.
Subject has uncontrolled blood pressure.
Subject is intolerant to heparin.
Subject is seroreactive for Hepatitis B Surface Antigen.
Subject has an active, life-threatening, rheumatologic disease.
Subject has a history of adverse reactions to dialyzer membrane material.
Subject is expected to receive an organ transplant during the course of the study.
Subject has a life-threatening malignancy actively receiving treatment that would prevent successful completion of the study protocol.
Clareo Health | The EvAluation of TaBlo In-CLinic and In-HOme
